Answers are grounded in this paper and cite their sources.
Shows hemodynamic benefits of 3-hydroxybutyrate in chronic heart failure patients, suggesting a new treatment option.
3-OHB has beneficial hemodynamic effects in HFrEF patients without impairing MEE. These beneficial effects are detectable in the physiological concentration range of circulating 3-OHB levels. The hemodynamic effects of 3-OHB were observed in both HFrEF patients and age-matched volunteers. 3-OHB may potentially constitute a novel treatment principle in HFrEF patients.
No takes yet. Share an insight, caveat, or question.
Nielsen et al. (2019) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: